Retrophin

FDA sets back Travere's plans for kidney disease drug approval
FDA sets back Travere's plans for kidney disease drug approval
Fierce Biotech
Travere Therapeutics
kidney disease
clinical trials
FDA
Retrophin
Martin Shkreli
Flag link:
Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics
Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics
Endpoints
Retrophin
Martin Shkreli
Travere Therapeutics
Flag link:
Retrophin to buy Orphan Tech for $90M upfront
Retrophin to buy Orphan Tech for $90M upfront
Seeking Alpha
Retrophin
Orphan Tech
M&A
enzyme replacement
Flag link:
Top 7 Companies in Biotech Beach by Revenue
Top 7 Companies in Biotech Beach by Revenue
BioSpace
Biotech Beach
San Diego
California
Amgen
Neurocrine
Acadia Pharmaceuticals
Retrophin
Tocagen
Mirati Therapeutics
AnaptysBio
Flag link:
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails
Xconomy
Retrophin
Martin Shkreli
fosmetpantotenate
Flag link:
Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes
Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes
Endpoints
Martin Shkreli
Retrophin
Flag link:
FDA Approves Retrophin’s New Formula for Cystine Kidney Stones
FDA Approves Retrophin’s New Formula for Cystine Kidney Stones
BioSpace
Retrophin
FDA
kidney stones
cystinuria
cystine kidney stones
Thiola
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Flag link:
FDA Action Alert: Regeneron, Sanofi, Celgene
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
Flag link:
After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin
After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin
Endpoints
Martin Shkreli
Retrophin
Flag link:
Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues
Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues
Endpoints
Martin Shkreli
Retrophin
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Go or no go? Merck, Regeneron and Alexion await US expansion
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
Flag link:
Made for TV: Shkreli running his drug company from prison cell, WSJ says
Made for TV: Shkreli running his drug company from prison cell, WSJ says
Fierce Pharma
Martin Shkreli
Phoenixus
Retrophin
Flag link:
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Endpoints
R&D
Martin Shkreli
RE-0024
Retrophin
Cyprus
clinical trials
Flag link:
From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
Fierce Pharma
Martin Shkreli
fraud
Retrophin
Flag link:
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Endpoints
Martin Shkreli
biotech
Retrophin
fraud
Flag link:
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Bizjournals.com
Retrophin
Cambridge
Martin Shkreli
Flag link:
Martin Shkreli in court as securities fraud case moves closer to trial
Martin Shkreli in court as securities fraud case moves closer to trial
CNBC
Martin Shkreli
securities fraud
Retrophin
Flag link:
4 Key BioPharma Movers in the Past Week
4 Key BioPharma Movers in the Past Week
24/7 Wall St
Retrophin
Evoke Pharma
Celgene
Lexicon Pharmaceuticals
Flag link:

Pages